LexaGene Holdings Inc. (CVE:LXG – Get Free Report)’s stock price traded down 19.2% during mid-day trading on Wednesday . The stock traded as low as C$0.10 and last traded at C$0.11. 2,135,377 shares were traded during trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Price Performance
The company has a quick ratio of 1.13, a current ratio of 1.39 and a debt-to-equity ratio of 138.01. The stock’s 50-day moving average price is C$0.11 and its 200 day moving average price is C$0.11. The firm has a market cap of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Further Reading
- Five stocks we like better than LexaGene
- The How And Why of Investing in Oil Stocks
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Trading Halts Explained
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- Comparing and Trading High PE Ratio Stocks
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
